River Vision Development Company
River Vision Development develops a protein therapy for the treatment of Graves orbitopathy.
Technology:
Immunotherapy
Industry:
PharmTech
Headquarters:
New York, New York, United States
Founded Date:
2011
Employees Number:
1-10
Funding Status:
M&A
Register and Claim Ownership